A case report of intraventricular and intrathecal tigecycline infusions for an extensively drug-resistant intracranial Acinetobacter baumannii infection

RATIONALE: The treatment of intracranial Acinetobacter baumannii infections is made difficult by multidrug-resistance poor drug penetration through the blood-brain barrier (BBB). Although tigecycline appears to be effective against A baumannii, it is only administered intravenously because it does n...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Zi-Wei, Wang, Jin, Qiu, Cheng-Feng, Yang, Yi, Shi, Zhi-Hua, Zhou, Jian-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485835/
https://www.ncbi.nlm.nih.gov/pubmed/30985683
http://dx.doi.org/10.1097/MD.0000000000015139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485835/
https://www.ncbi.nlm.nih.gov/pubmed/30985683
http://dx.doi.org/10.1097/MD.0000000000015139

Ejemplares similares